0
Vaccine Update
Vaccination of patients with altered immunocompetence
Stephan L. Foster; Christopher T. Short; Lauren B. Angelo
J Am Pharm Assoc (2003) 2013;53:438-440. doi:10.1331/JAPhA.2013.13526

Extract

Compared with the general population, patients with altered immunocompetence (AI) are at an increased risk of infection. Therefore, protecting them against vaccine-preventable diseases when respective vaccines are not otherwise contraindicated is important. Key issues to consider when deciding which vaccines are indicated include the type of AI, the degree of immunosuppression, the severity and prognosis of the potential vaccine-preventable disease, the type of vaccine, the safety and effectiveness of the vaccine, and timing of administration. Vaccination of those in close contact with immunosuppressed patients also is a critical component of providing protection from vaccine-preventable diseases.
Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

National Center for Immunization and Respiratory Diseases.  General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 2011; 60( 2): 1– 64.
 
McCusker C, Warrington R.  Primary immunodeficiency.  Allergy Asthma Clin Immunol. 2011; 7( suppl 1): S11.
 
Centers for Disease Control and Prevention.  Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence.  MMWR Recomm Rep.  1993; 42( RR-4): 1– 18.
 
Centers for Disease Control and Prevention.  Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine.  MMWR Morb Mortal Wkly Rep. 2010; 59( 22): 687– 8.
 
Centers for Disease Control and Prevention.  Epidemiology and prevention of vaccine-preventable diseases. 12th ed. Washington, DC:  Public Health Foundation;  2011.
 
Rotarix [package insert].  Research Triangle Park, NC:  GlaxoSmithKline;  2012.
 
RotaTeq [package insert].  West Point, PA:  Merck;  2012.
 
Centers for Disease Control and Prevention.  Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 2009; 58( RR-2): 1– 25.
 
Centers for Disease Control and Prevention.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.  MMWR Recomm Rep. 1992; 41( RR-17): 1– 19.
 
Levin MJ, Gershon AA, Weinberg A, et al.  Immunization of HIV-infected children with varicella vaccine.  J Pediatr. 2001; 139( 2): 305– 10.
 
Centers for Disease Control and Prevention.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 2007; 56( RR-4): 1– 40.
 
Watson JC, Hadler SC, Dykewicz CA, et al.  Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 1998; 47( RR-8): 1– 57.
 
Centers for Disease Control and Prevention.  Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 2013; 62( RR-2): 1– 28.
 
Brunton LL (Ed.):  ACTH, adrenal steroids, and pharmacology of the adrenal cortex. In:  Goodman & Gilman's the pharmacological basis of therapeutics. 12th ed.  New York:  McGraw-Hill;  2010.
 
Centers for Disease Control and Prevention.  Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MWR Morb Mortal Wkly Rep. 2012; 61( 40): 816– 9.
 
Centers for Disease Control and Prevention.  Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 2010; 59( RR-11): 1– 18.
 
Angelo LB.  APhA's immunization handbook. 2nd ed.  Washington, DC:  American Pharmacists Association;  2012.
 
Centers for Disease Control and Prevention.  Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older: United States, 2013.  MMWR Surveill Summ. 2013; 62( suppl 1): 1.
 
AST Infectious Diseases Community of Practice.  Vaccination in solid organ transplantation.  Am J Transplant. 2013; 13( suppl 4): 311– 7.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints